- Report
- December 2024
- 581 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- October 2024
- 180 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- October 2024
- 181 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- July 2024
- 150 Pages
Global
From €5657EUR$5,950USD£4,757GBP
- Report
- July 2024
- 100 Pages
Global
From €5657EUR$5,950USD£4,757GBP
- Report
- March 2025
- 224 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- February 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- March 2025
- 250 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- July 2024
- 135 Pages
Global
From €2851EUR$2,999USD£2,398GBP
- Report
- February 2025
- 185 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- September 2024
- 183 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Clinical Trials
- November 2024
- 450 Pages
Global
From €4754EUR$5,000USD£3,998GBP
- Report
- January 2025
- 180 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- January 2025
- 180 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- December 2024
- 200 Pages
Global
From €3566EUR$3,750USD£2,998GBP
- Report
- October 2024
- 200 Pages
Global
From €3566EUR$3,750USD£2,998GBP
- Report
- August 2024
- 268 Pages
Global
From €3423EUR$3,600USD£2,878GBP
- Newsletter
- March 2025
- 88 Pages
Global
€1253EUR$1,318USD£1,054GBP
- Report
- March 2022
- 182 Pages
Global
From €2496EUR$2,625USD£2,099GBP
€4992EUR$5,250USD£4,197GBP

The Solid Tumor market within the context of Oncology is a highly competitive and rapidly evolving field. It is focused on the development of treatments for solid tumors, which are malignant tumors that form in the body's organs and tissues. These tumors can be caused by a variety of factors, including genetic mutations, environmental exposures, and lifestyle choices. Treatment options for solid tumors include surgery, chemotherapy, radiation therapy, and targeted therapies.
The Solid Tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. Companies in this market are focused on developing innovative treatments and therapies to improve patient outcomes. Examples of companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more